175 related articles for article (PubMed ID: 12090409)
1. Statistical power in randomized intervention studies with noncompliance.
Jo B
Psychol Methods; 2002 Jun; 7(2):178-93. PubMed ID: 12090409
[TBL] [Abstract][Full Text] [Related]
2. Causal inference methods to assess safety upper bounds in randomized trials with noncompliance.
Wang Y; Berlin JA; Pinheiro J; Wilcox MA
Clin Trials; 2015 Jun; 12(3):265-75. PubMed ID: 25733675
[TBL] [Abstract][Full Text] [Related]
3. Cluster randomized trials with treatment noncompliance.
Jo B; Asparouhov T; Muthén BO; Ialongo NS; Brown CH
Psychol Methods; 2008 Mar; 13(1):1-18. PubMed ID: 18331150
[TBL] [Abstract][Full Text] [Related]
4. Noncompliance in cancer screening trials.
Gareen IF
Clin Trials; 2007; 4(4):341-9. PubMed ID: 17848495
[TBL] [Abstract][Full Text] [Related]
5. Testing homogeneity of the risk ratio in stratified noncompliance randomized trials.
Lui KJ
Contemp Clin Trials; 2007 Sep; 28(5):614-25. PubMed ID: 17409026
[TBL] [Abstract][Full Text] [Related]
6. An extended general location model for causal inferences from data subject to noncompliance and missing values.
Peng Y; Little RJ; Raghunathan TE
Biometrics; 2004 Sep; 60(3):598-607. PubMed ID: 15339281
[TBL] [Abstract][Full Text] [Related]
7. Estimating the Complier Average Causal Effect in a Meta-Analysis of Randomized Clinical Trials With Binary Outcomes Accounting for Noncompliance: A Generalized Linear Latent and Mixed Model Approach.
Zhou T; Zhou J; Hodges JS; Lin L; Chen Y; Cole SR; Chu H
Am J Epidemiol; 2022 Jan; 191(1):220-229. PubMed ID: 34564720
[TBL] [Abstract][Full Text] [Related]
8. Regarding paper "Five interval estimators for proportion ratio under a stratified randomized clinical trial with noncompliance" by Lui K. J. and Chang K. C.
Vach W
Biom J; 2007 Aug; 49(4):627-9; author reply 630-1. PubMed ID: 17722194
[No Abstract] [Full Text] [Related]
9. Dichotomizing partial compliance and increased participant burden in factorial designs: the performance of four noncompliance methods.
Merrill PD; McClure LA
Trials; 2015 Nov; 16():523. PubMed ID: 26573840
[TBL] [Abstract][Full Text] [Related]
10. Analysis of times to repeated events in two-arm randomized trials with noncompliance and dependent censoring.
Matsui S
Biometrics; 2004 Dec; 60(4):965-76. PubMed ID: 15606417
[TBL] [Abstract][Full Text] [Related]
11. Five interval estimators for proportion ratio under a stratified randomized clinical trial with noncompliance.
Lui KJ; Chang KC
Biom J; 2007 Aug; 49(4):613-26. PubMed ID: 17634977
[TBL] [Abstract][Full Text] [Related]
12. Estimating treatment effects in randomized clinical trials with non-compliance: the impact of maternal smoking on birthweight.
Hamilton BH
Health Econ; 2001 Jul; 10(5):399-410. PubMed ID: 11466802
[TBL] [Abstract][Full Text] [Related]
13. Bounds on the average causal effects in randomized trials with noncompliance by covariate adjustment.
Shan N; Xu PF
Biom J; 2016 Nov; 58(6):1311-1318. PubMed ID: 27062639
[TBL] [Abstract][Full Text] [Related]
14. Assessing complier average causal effects from longitudinal trials with multiple endpoints and treatment noncompliance: An application to a study of Arthritis Health Journal.
Guo L; Qian Y; Xie H
Stat Med; 2022 Jun; 41(13):2448-2465. PubMed ID: 35274333
[TBL] [Abstract][Full Text] [Related]
15. A Bayesian hierarchical model estimating CACE in meta-analysis of randomized clinical trials with noncompliance.
Zhou J; Hodges JS; Suri MFK; Chu H
Biometrics; 2019 Sep; 75(3):978-987. PubMed ID: 30690716
[TBL] [Abstract][Full Text] [Related]
16. Sample size calculation in survival trials accounting for time-varying relationship between noncompliance and risk of outcome event.
Li B; Grambsch P
Clin Trials; 2006; 3(4):349-59. PubMed ID: 17060209
[TBL] [Abstract][Full Text] [Related]
17. An alternative method for population pharmacokinetic data analysis under noncompliance.
Gupta P; Hutmacher MM; Frame B; Miller R
J Pharmacokinet Pharmacodyn; 2008 Apr; 35(2):219-33. PubMed ID: 18299967
[TBL] [Abstract][Full Text] [Related]
18. Intention-to-treat analysis in cluster randomized trials with noncompliance.
Jo B; Asparouhov T; Muthén BO
Stat Med; 2008 Nov; 27(27):5565-77. PubMed ID: 18623608
[TBL] [Abstract][Full Text] [Related]
19. Multiple imputation methods for treatment noncompliance and nonresponse in randomized clinical trials.
Taylor L; Zhou XH
Biometrics; 2009 Mar; 65(1):88-95. PubMed ID: 18397338
[TBL] [Abstract][Full Text] [Related]
20. Estimating intervention effects of prevention programs: accounting for noncompliance.
Stuart EA; Perry DF; Le HN; Ialongo NS
Prev Sci; 2008 Dec; 9(4):288-98. PubMed ID: 18843535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
